Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment

DSpace Repository

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment

Author: Seitz, Christian Martin; Flaadt, Tim; Mezger, Markus; Lang, Anne-Marie; Michaelis, Sebastian; Katz, Marie; Syring, Desiree; Joechner, Alexander; Rabsteyn, Armin; Siebert, Nikolai; Troschke-Meurer, Sascha; Zumpe, Maxi; Lode, Holger N.; Yang, Sile F.; Atar, Daniel; Mast, Anna-Sophia; Scheuermann, Sophia; Heubach, Florian; Handgretinger, Rupert; Lang, Peter; Schlegel, Patrick
Tübinger Autor(en):
Seitz, Christian
Flaadt, Tim
Mezger, Markus
Lang, Anne-Marie
Michaelis, Sebastian
Katz, Marie
Syring, Desiree
Rabsteyn, Armin
Atar, Daniel
Mast, Anna-Sophia
Scheuermann, Sophia
Heubach, Florian
Handgretinger, Rupert
Lang, Peter
Schlegel, Patrick
Jöchner, Alexander
Published in: Frontiers in Immunology (2021), Bd. 12, Article 690467
Verlagsangabe: Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fimmu.2021.690467
ISSN: 1664-3224
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)